City

Bologna (1)

Overall Status

Not yet recruiting (2)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 2 (1)

Sponsor

Kura Oncology, Inc. (2)

Gruppo Italiano Malattie EMatologiche dell'Adulto (1)

Collaborator

Study Documents

Intervention Type

drug (3)

biological (1)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

npm1 mutation

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

Not yet recruiting

AML
+11 more

Ziftomenib
+5 more

(no location specified)

Aug 14, 2023

Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,

Not yet recruiting

Acute Myeloid Leukemia
+10 more

Ziftomenib
+4 more

(no location specified)

Feb 17, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse, NPM1 Mutation Trial in Bologna (Venetoclax+azacitidine)

Recruiting

Acute Myeloid Leukemia
+2 more

Venetoclax+azacitidine

Bologna, Italy

EMATOLOGIA- AOU Policlinico S.Orsola

Mar 1, 2022